Mackenzie Financial Corp Raises Stake in Viemed Healthcare, Inc. (NASDAQ:VMD)

Mackenzie Financial Corp boosted its position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 225.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 64,433 shares of the company's stock after buying an additional 44,636 shares during the period. Mackenzie Financial Corp owned approximately 0.17% of Viemed Healthcare worth $517,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the company. Man Group plc purchased a new stake in Viemed Healthcare in the fourth quarter valued at approximately $95,000. Nuveen Asset Management LLC lifted its holdings in Viemed Healthcare by 22.1% in the fourth quarter. Nuveen Asset Management LLC now owns 162,272 shares of the company's stock valued at $1,301,000 after acquiring an additional 29,320 shares during the period. Millennium Management LLC acquired a new position in shares of Viemed Healthcare during the 4th quarter worth approximately $573,000. Lazard Asset Management LLC raised its stake in shares of Viemed Healthcare by 34.9% during the 4th quarter. Lazard Asset Management LLC now owns 43,598 shares of the company's stock worth $349,000 after buying an additional 11,273 shares during the period. Finally, Expect Equity LLC purchased a new stake in shares of Viemed Healthcare during the fourth quarter worth approximately $1,369,000. Hedge funds and other institutional investors own 74.24% of the company's stock.

Viemed Healthcare Price Performance

Shares of VMD traded up $0.13 during trading hours on Friday, hitting $6.72. 195,656 shares of the stock were exchanged, compared to its average volume of 140,253. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. Viemed Healthcare, Inc. has a 12-month low of $6.14 and a 12-month high of $9.81. The company has a market cap of $265.60 million, a price-to-earnings ratio of 24.89 and a beta of 1.38. The stock's 50-day moving average price is $6.76 and its two-hundred day moving average price is $7.60.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The firm had revenue of $59.10 million during the quarter, compared to analysts' expectations of $60.60 million.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.